HealthLawProf Blog

Editor: Katharine Van Tassel
Concordia University School of Law

Monday, August 8, 2011

FDA Approves First-Ever Scorpion Sting Treatment: Who Knew?

I had no idea that scorpion stings were so frequent and that there was no treatment -- until now. According to a press release about the new product called Anascorp, produced by a Mexican company called Instituto Bioclon and licensed to Rare Disease Therapeutics:

[v]enomous scorpions (Centuroides) in the U.S. are mostly found in Arizona. Severe stings occur most frequently in infants and children, and can cause shortness of breath, fluid in the lungs, breathing problems, excess saliva, blurred vision, slurred speech, trouble swallowing, abnormal eye movements, muscle twitching, trouble walking, and other uncoordinated muscle movements. Untreated cases can be fatal.

Hat tip to Clifford S. Mintz, PhD over at BioJobBlog. [KVT]

| Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference FDA Approves First-Ever Scorpion Sting Treatment: Who Knew?:


Post a comment